Xiangyu Medical Co. Ltd. A (688626) — Cash Flow Reinvestment Rate
Xiangyu Medical Co. Ltd. A (688626) has a Cash Flow Reinvestment Rate of 3.23x as of September 2025, reinvesting CN¥58.35 Million (capex CN¥58.35 Million ) from operating cash flow of CN¥18.05 Million. Explore Xiangyu Medical Co. Ltd. A capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xiangyu Medical Co. Ltd. A Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for Xiangyu Medical Co. Ltd. A across 8 annual periods. Also explore Xiangyu Medical Co. Ltd. A balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xiangyu Medical Co. Ltd. A (2017–2024)
Year-by-year capital reinvestment analysis for Xiangyu Medical Co. Ltd. A. For live market cap and broader valuation context, see Xiangyu Medical Co. Ltd. A stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.46x | CN¥439.95 Million | CN¥178.59 Million | CN¥438.89 Million | ▼ -21.3% |
| 2023 | 3.13x | CN¥713.80 Million | CN¥227.91 Million | CN¥479.26 Million | ▲ +53.1% |
| 2022 | 2.05x | CN¥381.98 Million | CN¥186.70 Million | CN¥203.07 Million | ▼ -62.9% |
| 2021 | 5.52x | CN¥915.95 Million | CN¥165.88 Million | CN¥133.91 Million | ▲ +328.1% |
| 2020 | 1.29x | CN¥279.12 Million | CN¥216.40 Million | CN¥139.71 Million | ▼ -4.3% |
| 2019 | 1.35x | CN¥210.20 Million | CN¥155.94 Million | CN¥21.07 Million | ▲ +1325.5% |
| 2018 | 0.09x | CN¥7.02 Million | CN¥74.20 Million | CN¥7.02 Million | ▼ -62.2% |
| 2017 | 0.25x | CN¥14.84 Million | CN¥59.31 Million | CN¥14.84 Million | — |